Company Description
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada.
The company operates through three segments: Dental, Animal Health, and Corporate. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; and practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, and patient engagement solutions, as well as clinical and patient education systems.
This segment also provides a range of related services comprising software and design, maintenance and repair, and equipment financing services.
The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional’s, consumable supplies, and equipment, as well as value-added services.
This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands.
The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers.
The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004.
Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
| Country | United States |
| Founded | 1877 |
| IPO Date | Oct 28, 1992 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 7,600 |
| CEO | Donald Zurbay |
Contact Details
Address: 1031 Mendota Heights Road Saint Paul, Minnesota 55120 United States | |
| Phone | 651 686 1600 |
| Website | pattersoncompanies.com |
Stock Details
| Ticker Symbol | PDCO |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| CIK Code | 0000891024 |
| CUSIP Number | 703395103 |
| ISIN Number | US7033951036 |
| Employer ID | 41-0886515 |
| SIC Code | 5047 |
Key Executives
| Name | Position |
|---|---|
| Donald Zurbay | Chief Executive Officer |
| Kevin Barry | Chief Financial Officer |
| Kevin Pohlman | Chief Operating Officer |
| John Wright | Head of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 13, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 13, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 11, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 11, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 11, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 11, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 11, 2024 | 8-K | Current Report |
| Dec 5, 2024 | 10-Q | Quarterly Report |
| Dec 5, 2024 | 8-K | Current Report |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |